Ulcerative Colitis
On this page:
What is ulcerative colitis?
Ulcerative colitis is a disease that causes inflammation and
sores, called ulcers, in the lining of the rectum and colon. Ulcers
form where inflammation has killed the cells that usually line the
colon, then bleed and produce pus. Inflammation in the colon also
causes the colon to empty frequently, causing diarrhea.
When the inflammation occurs in the rectum and lower part of the
colon it is called ulcerative proctitis. If the entire colon is
affected it is called pancolitis. If only the left side of the colon
is affected it is called limited or distal colitis.
Ulcerative colitis is an inflammatory bowel disease (IBD), the
general name for diseases that cause inflammation in the small
intestine and colon. It can be difficult to diagnose because its
symptoms are similar to other intestinal disorders and to another
type of IBD called Crohn’s disease. Crohn’s disease differs because
it causes inflammation deeper within the intestinal wall and can
occur in other parts of the digestive system including the small
intestine, mouth, esophagus, and stomach.
Ulcerative colitis can occur in people of any age, but it usually
starts between the ages of 15 and 30, and less frequently between 50
and 70 years of age. It affects men and women equally and appears to
run in families, with reports of up to 20 percent of people with
ulcerative colitis having a family member or relative with
ulcerative colitis or Crohn’s disease. A higher incidence of
ulcerative colitis is seen in Whites and people of Jewish
descent.
[Top]
What are the symptoms of ulcerative colitis?
The most common symptoms of ulcerative colitis are abdominal pain
and bloody diarrhea. Patients also may experience
- anemia
- fatigue
- weight loss
- loss of appetite
- rectal bleeding
- loss of body fluids and nutrients
- skin lesions
- joint pain
- growth failure (specifically in children)
About half of the people diagnosed with ulcerative colitis have
mild symptoms. Others suffer frequent fevers, bloody diarrhea,
nausea, and severe abdominal cramps. Ulcerative colitis may also
cause problems such as arthritis, inflammation of the eye, liver
disease, and osteoporosis. It is not known why these problems occur
outside the colon. Scientists think these complications may be the
result of inflammation triggered by the immune system. Some of these
problems go away when the colitis is treated.
[Top]
What causes ulcerative colitis?
Many theories exist about what causes ulcerative colitis. People
with ulcerative colitis have abnormalities of the immune system, but
doctors do not know whether these abnormalities are a cause or a
result of the disease. The body’s immune system is believed to react
abnormally to the bacteria in the digestive tract.
Ulcerative colitis is not caused by emotional distress or
sensitivity to certain foods or food products, but these factors may
trigger symptoms in some people. The stress of living with
ulcerative colitis may also contribute to a worsening of
symptoms.
[Top]
How is ulcerative colitis diagnosed?
Many tests are used to diagnose ulcerative colitis. A physical
exam and medical history are usually the first step.
Blood tests may be done to check for anemia, which could indicate
bleeding in the colon or rectum, or they may uncover a high white
blood cell count, which is a sign of inflammation somewhere in the
body.
A stool sample can also reveal white blood cells, whose presence
indicates ulcerative colitis or inflammatory disease. In addition, a
stool sample allows the doctor to detect bleeding or infection in
the colon or rectum caused by bacteria, a virus, or parasites.
A colonoscopy or sigmoidoscopy are the most accurate methods for
making a diagnosis of ulcerative colitis and ruling-out other
possible conditions, such as Crohn’s disease, diverticular disease,
or cancer. For both tests, the doctor inserts an endoscope—a long,
flexible, lighted tube connected to a computer and TV monitor—into
the anus to see the inside of the colon and rectum. The doctor will
be able to see any inflammation, bleeding, or ulcers on the colon
wall. During the exam, the doctor may do a biopsy, which involves
taking a sample of tissue from the lining of the colon to view with
a microscope.
Sometimes x rays such as a barium enema or CT scans are also used
to diagnose ulcerative colitis or its complications.
[Top]
What is the treatment for ulcerative colitis?
Treatment for ulcerative colitis depends on the severity of the
disease. Each person experiences ulcerative colitis differently, so
treatment is adjusted for each individual.
Drug Therapy
The goal of drug therapy is to induce and maintain remission, and
to improve the quality of life for people with ulcerative colitis.
Several types of drugs are available.
- Aminosalicylates, drugs that contain 5-aminosalicyclic
acid (5-ASA), help control inflammation. Sulfasalazine is a
combination of sulfapyridine and 5-ASA. The sulfapyridine
component carries the anti-inflammatory 5-ASA to the intestine.
However, sulfapyridine may lead to side effects such as nausea,
vomiting, heartburn, diarrhea, and headache. Other 5-ASA agents,
such as olsalazine, mesalamine, and balsalazide, have a different
carrier, fewer side effects, and may be used by people who cannot
take sulfasalazine. 5-ASAs are given orally, through an enema, or
in a suppository, depending on the location of the inflammation in
the colon. Most people with mild or moderate ulcerative colitis
are treated with this group of drugs first. This class of drugs is
also used in cases of relapse.
- Corticosteroids such as prednisone, methylprednisone,
and hydrocortisone also reduce inflammation. They may be used by
people who have moderate to severe ulcerative colitis or who do
not respond to 5-ASA drugs. Corticosteroids, also known as
steroids, can be given orally, intravenously, through an enema, or
in a suppository, depending on the location of the inflammation.
These drugs can cause side effects such as weight gain, acne,
facial hair, hypertension, diabetes, mood swings, bone mass loss,
and an increased risk of infection. For this reason, they are not
recommended for long-term use, although they are considered very
effective when prescribed for short-term use.
- Immunomodulators such as azathioprine and
6-mercapto-purine (6-MP) reduce inflammation by affecting the
immune system. These drugs are used for patients who have not
responded to 5-ASAs or corticosteroids or who are dependent on
corticosteroids. Immunomodulators are administered orally,
however, they are slow-acting and it may take up to 6 months
before the full benefit. Patients taking these drugs are monitored
for complications including pancreatitis, hepatitis, a reduced
white blood cell count, and an increased risk of infection.
Cyclosporine A may be used with 6-MP or azathioprine to treat
active, severe ulcerative colitis in people who do not respond to
intravenous corticosteroids.
Other drugs may be given to relax the patient or to relieve pain,
diarrhea, or infection.
Some people have remissions—periods when the symptoms go
away—that last for months or even years. However, most patients’
symptoms eventually return.
Hospitalization
Occasionally, symptoms are severe enough that a person must be
hospitalized. For example, a person may have severe bleeding or
severe diarrhea that causes dehydration. In such cases the doctor
will try to stop diarrhea and loss of blood, fluids, and mineral
salts. The patient may need a special diet, feeding through a vein,
medications, or sometimes surgery.
Surgery
About 25 to 40 percent of ulcerative colitis patients must
eventually have their colons removed because of massive bleeding,
severe illness, rupture of the colon, or risk of cancer. Sometimes
the doctor will recommend removing the colon if medical treatment
fails or if the side effects of corticosteroids or other drugs
threaten the patient’s health.
Surgery to remove the colon and rectum, known as proctocolectomy,
is followed by one of the following:
- Ileostomy, in which the surgeon creates a small opening
in the abdomen, called a stoma, and attaches the end of the small
intestine, called the ileum, to it. Waste will travel through the
small intestine and exit the body through the stoma. The stoma is
about the size of a quarter and is usually located in the lower
right part of the abdomen near the beltline. A pouch is worn over
the opening to collect waste, and the patient empties the pouch as
needed.
- Ileoanal anastomosis, or pull-through operation, which
allows the patient to have normal bowel movements because it
preserves part of the anus. In this operation, the surgeon removes
the colon and the inside of the rectum, leaving the outer muscles
of the rectum. The surgeon then attaches the ileum to the inside
of the rectum and the anus, creating a pouch. Waste is stored in
the pouch and passes through the anus in the usual manner. Bowel
movements may be more frequent and watery than before the
procedure. Inflammation of the pouch (pouchitis) is a possible
complication.
Not every operation is appropriate for every person. Which
surgery to have depends on the severity of the disease and the
patient’s needs, expectations, and lifestyle. People faced with this
decision should get as much information as possible by talking to
their doctors, to nurses who work with colon surgery patients
(enterostomal therapists), and to other colon surgery patients.
Patient advocacy organizations can direct people to support groups
and other information resources.
[Top]
Is colon cancer a concern?
About 5 percent of people with ulcerative colitis develop colon
cancer. The risk of cancer increases with the duration of the
disease and how much the colon has been damaged. For example, if
only the lower colon and rectum are involved, the risk of cancer is
no higher than normal. However, if the entire colon is involved, the
risk of cancer may be as much as 32 times the normal rate.
Sometimes precancerous changes occur in the cells lining the
colon. These changes are called "dysplasia." People who have
dysplasia are more likely to develop cancer than those who do not.
Doctors look for signs of dysplasia when doing a colonoscopy or
sigmoidoscopy and when examining tissue removed during these
tests.
According to the 2002 updated guidelines for colon cancer
screening, people who have had IBD throughout their colon for at
least 8 years and those who have had IBD in only the left colon for
12 to 15 years should have a colonoscopy with biopsies every 1 to 2
years to check for dysplasia. Such screening has not been proven to
reduce the risk of colon cancer, but it may help identify cancer
early. These guidelines were produced by an independent expert panel
and endorsed by numerous organizations, including the American
Cancer Society, the American College of Gastroenterology, the
American Society of Colon and Rectal Surgeons, and the Crohn’s &
Colitis Foundation of America.
[Top]
Hope Through Research
NIDDK, through the Division of Digestive Diseases and Nutrition,
conducts and supports research into many kinds of digestive
disorders, including ulcerative colitis. Researchers are studying
how and why the immune system is activated, how it damages the
colon, and the processes involved in healing. Through this increased
understanding, new and more specific therapies can be developed.
Currently, there are numerous clinical trials being conducted that
are investigating ulcerative colitis. A complete listing of research
studies on ulcerative colitis may be found at http://www.clinicaltrials.gov/.
[Top]
For More Information
Crohn's & Colitis Foundation of America
386 Park
Avenue South, 17th floor
New York, NY 10016–8804
Phone:
1–800–932–2423 or 212–685–3440
Fax: 212–779–4098
Email: info@ccfa.org
Internet: http://www.ccfa.org/
Reach Out for Youth With Ileitis and Colitis Inc.
84
Northgate Circle
Melville, NY 11747
Phone:
631–293–3102
Fax: 631–293–3103
Email: reachoutforyouth@reachoutforyouth.org
Internet: http://www.reachoutforyouth.org/
United Ostomy Association
19772 MacArthur Boulevard,
Suite 200
Irvine, CA 92612–2405
Phone: 1–800–826–0826 or
949–660–8624
Fax: 949–660–9262
Email: info@uoa.org
Internet: http://www.uoa.org/
[Top]
The U.S. Government does not endorse or favor any specific
commercial product or company. Trade, proprietary, or company names
appearing in this document are used only because they are considered
necessary in the context of the information provided. If a product
is not mentioned, the omission does not mean or imply that the
product is unsatisfactory.
National Digestive Diseases Information Clearinghouse
2 Information Way
Bethesda, MD 20892–3570
Email: http://digestive.niddk.nih.gov/about/contact.htm
The National Digestive Diseases Information Clearinghouse (NDDIC)
is a service of the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK). The NIDDK is part of the National
Institutes of Health of the U.S. Department of Health and Human
Services. Established in 1980, the Clearinghouse provides
information about digestive diseases to people with digestive
disorders and to their families, health care professionals, and the
public. The NDDIC answers inquiries, develops and distributes
publications, and works closely with professional and patient
organizations and Government agencies to coordinate resources about
digestive diseases.
Publications produced by the Clearinghouse are carefully reviewed
by both NIDDK scientists and outside experts. This publication was
originally reviewed by This publication was reviewed by the Crohn’s
& Colitis Foundation of America.
This publication is not copyrighted. The Clearinghouse encourages
users of this publication to duplicate and distribute as many copies
as desired.
NIH Publication No. 05–4332
November 2004
[Top]
|